Attached files
| file | filename |
|---|---|
| EX-99.1 - EXHIBIT 99.1 - AIkido Pharma Inc. | s102681_ex99-1.htm |
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
____________________________________________________________
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
____________________________________________________________
Date of Report (Date of earliest event reported): February 22, 2016
| SPHERIX INCORPORATED | ||
| (Exact Name of Registrant as Specified in Charter) |
| Delaware | 0-5576 | 52-0849320 | ||
| (State or other jurisdiction | (Commission File Number) | (IRS Employer Identification No.) | ||
| of incorporation) |
| 6430 Rockledge Drive, Suite 503 | ||||
| Bethesda, MD | 20817 | |||
| (Address of principal executive offices) | (Zip Code) |
Registrant’s telephone number, including area code: (703) 992-9260
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Item 8.01 Other Events.
The Company announced today that it adjourned its special meeting of stockholders to February 26, 2016, at 3:00 p.m. Eastern time. The adjourned meeting will be held at 437 Madison Avenue, 24th Floor, New York, NY 10022. A copy of the press release is attached.
Item 9.01. Financial Statements and Exhibits
| d) | Exhibits. |
The exhibit listed in the following Exhibit Index is filed as part of this Current Report on Form 8-K.
| Exhibit No. | Description | |
| 99.1 | Press Release, dated February 22, 2016 |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
Date: February 22, 2015
| SPHERIX INCORPORATED | ||
| By: | /s/ Anthony Hayes | |
| Name: Anthony Hayes | ||
| Title: Chief Executive Officer |